No profile data available.
Organogenesis Holdings Inc. (ORGO) is a healthcare company in the additional specific healthcare equipment industry, based in Canton, United States, with about 854 full-time employees.
It reported revenue of $563.03 million for fiscal year 2025, up 16.8% from fiscal year 2024, and net income of $20.02 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $42.81 million, down 57.5% from a year before. Its market capitalization was $165.99 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
Organogenesis reported $563.03 million in revenue for fiscal year 2025, up 16.8% from $482.04 million in fiscal year 2024. In Q2 2026 revenue was $42.81 million.
$165.99 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional specific healthcare equipment) include Cerus Corporation (CERS), Avita Medical, Inc. (RCEL), Sanara MedTech Inc. (SMTI), Apyx Medical Corporation (APYX).